{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:26:34Z","timestamp":1789989994899,"version":"4.0.1"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1111\/j.1574-6968.2006.00224.x","type":"journal-article","created":{"date-parts":[[2006,4,3]],"date-time":"2006-04-03T10:48:01Z","timestamp":1144061281000},"page":"200-203","source":"Crossref","is-referenced-by-count":68,"title":["The potential of azole antifungals against latent\/persistent tuberculosis"],"prefix":"10.1093","volume":"258","author":[{"given":"Zahoor","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal K.","family":"Khuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1574-6968.2006.00224.x-BIB1","doi-asserted-by":"crossref","unstructured":"Betts JC , Lukey PT , Robb LC , et al. (2002) Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 43: 717\u00e2\u0080\u0093731.","DOI":"10.1046\/j.1365-2958.2002.02779.x"},{"key":"10.1111\/j.1574-6968.2006.00224.x-BIB2","doi-asserted-by":"crossref","unstructured":"Brooks JV , Furney SK & Orme IM (1999) Metronidazole therapy in mice infected with tuberculosis. Antimicrob Agents Chemother 43: 1285\u00e2\u0080\u00931288.","DOI":"10.1128\/AAC.43.5.1285"},{"key":"10.1111\/j.1574-6968.2006.00224.x-BIB3","unstructured":"Heifets L , Simon J & Pham V (2005) Capreomycin is active against non-replicating Mycobacterium tuberculosis. Ann Clin Microbiol Antimicrob 4: 6\u00e2\u0080\u009312."},{"key":"10.1111\/j.1574-6968.2006.00224.x-BIB4","doi-asserted-by":"crossref","unstructured":"Lowrie DB , Tascon RE , Bonato VLD , et al. (1999) Therapy of tuberculosis in mice by DNA vaccination. Nature 400: 269\u00e2\u0080\u0093271.","DOI":"10.1038\/22326"},{"key":"10.1111\/j.1574-6968.2006.00224.x-BIB5","doi-asserted-by":"crossref","unstructured":"McLean KJ , Marshall KR , Richmond A , Hunter IS , Fowler K , Kieser T , Gurcha SS , Besra GS & Munro AW (2002) Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes. Microbiology 148: 2937\u00e2\u0080\u00932949.","DOI":"10.1099\/00221287-148-10-2937"},{"key":"10.1111\/j.1574-6968.2006.00224.x-BIB6","doi-asserted-by":"crossref","unstructured":"Medinger A (2002) Death associated with rifampin and pyrazinamide, 2-month treatment of latent Mycobacterium tuberculosis. Chest 121: 1710\u00e2\u0080\u00931712.","DOI":"10.1378\/chest.121.5.1710"},{"key":"10.1111\/j.1574-6968.2006.00224.x-BIB7","unstructured":"Murugasu B & Dick T (2002) Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG. J Antimicrob Chemother 46: 917\u00e2\u0080\u0093919."},{"key":"10.1111\/j.1574-6968.2006.00224.x-BIB8","unstructured":"Nikki MP , Dick JD & Bishai WR (1998) Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol 6: 107\u00e2\u0080\u0093112."},{"key":"10.1111\/j.1574-6968.2006.00224.x-BIB9","unstructured":"Rosenkrands I , Slayden RA , Crawford J , et al. (2002) Hypoxic response of Mycobacterium tuberculosis studied by metabolic labelling and proteome analysis of cellular and extracellular proteins. J Bacteriol 184: 3485\u00e2\u0080\u00933491."},{"key":"10.1111\/j.1574-6968.2006.00224.x-BIB10","doi-asserted-by":"crossref","unstructured":"Scanga CA , Mohan VP , Joseph H , et al. (1999) Reactivation of latent tuberculosis: variations on the Cornell murine model. Infect Immun 67: 4531\u00e2\u0080\u00934538.","DOI":"10.1128\/IAI.67.9.4531-4538.1999"},{"key":"10.1111\/j.1574-6968.2006.00224.x-BIB11","unstructured":"Sun Z & Zhang Y (1999) Antitubercular activities of certain antifungal and antihelminthic drugs. Tuber Lung Dis 79: 319\u00e2\u0080\u0093320."},{"key":"10.1111\/j.1574-6968.2006.00224.x-BIB12","unstructured":"Veeraraghavan U , Jayaraman R , Toro JC , et al. (2002) Glycine and alanine dehydrogenase activities are catalyzed by the same protein in Mycobacterium smegmatis: up regulation of both activities under microaerophilic adaptation. Can J Microbiol 48: 7\u00e2\u0080\u009313."},{"key":"10.1111\/j.1574-6968.2006.00224.x-BIB13","unstructured":"Wayne LG & Sramek HA (1994) Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob Agents Chemother 38: 2054\u00e2\u0080\u00932058."},{"key":"10.1111\/j.1574-6968.2006.00224.x-BIB14","unstructured":"Zahoor A , Sharma S & Khuller GK (2005) In vitro and ex vivo antimycobacterial potential of azole drugs against Mycobacterium tuberculosis H37RV. FEMS Microbiol Lett 251: 19\u00e2\u0080\u009322."}],"container-title":["FEMS Microbiology Letters"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femsle\/article-pdf\/258\/2\/200\/19127471\/258-2-200.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T15:15:28Z","timestamp":1706973328000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femsle\/article-lookup\/doi\/10.1111\/j.1574-6968.2006.00224.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1574-6968.2006.00224.x","relation":{},"ISSN":["0378-1097","1574-6968"],"issn-type":[{"value":"0378-1097","type":"print"},{"value":"1574-6968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}